Spyros Papapetropoulos
2021
In 2021, Spyros Papapetropoulos earned a total compensation of $1.1M as Chief Medical Officer at Vigil Neuroscience, a 91% increase compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $154,805 |
| Option Awards | $533,148 |
| Salary | $396,935 |
| Total | $1,134,888 |
Papapetropoulos received $533.1K in option awards, accounting for 47% of the total pay in 2021.
Papapetropoulos also received $50K in bonus, $154.8K in non-equity incentive plan and $396.9K in salary.
Rankings
In 2021, Spyros Papapetropoulos' compensation ranked 8,354th out of 12,415 executives tracked by ExecPay. In other words, Papapetropoulos earned more than 32.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,354 out of 12,415 | 33rd |
Division Manufacturing | 3,698 out of 5,505 | 33rd |
Major group Chemicals And Allied Products | 1,645 out of 2,375 | 31st |
Industry group Drugs | 1,463 out of 2,096 | 30th |
Industry Biological Products, Except Diagnostic Substances | 324 out of 449 | 28th |
Source: SEC filing on April 28, 2022.
Papapetropoulos' colleagues
We found two more compensation records of executives who worked with Spyros Papapetropoulos at Vigil Neuroscience in 2021.